Welcome to our dedicated page for KKR & Co. news (Ticker: KKR), a resource for investors and traders seeking the latest updates and insights on KKR & Co. stock.
KKR & Co. Inc. (NYSE: KKR), founded in 1976 by Henry Kravis and George Roberts, is a leading global investment firm managing investments across various asset classes such as private equity, energy, infrastructure, real estate, credit, and hedge funds. Headquartered in New York, KKR aims to generate attractive investment returns through a patient and disciplined investment approach, employing world-class talent, and driving growth and value creation at the asset level.
As of March 2023, KKR boasts an impressive $577.6 billion in total managed assets, which includes $470.6 billion in fee-earning assets under management (AUM). KKR operates through two primary segments: Asset Management and Insurance. The Asset Management segment involves private markets (private equity, credit, infrastructure, energy, and real estate) and public markets (primarily credit and hedge/investment fund platforms). The Insurance segment follows KKR's acquisition of Global Atlantic Financial Group, focusing on retirement, annuity, life insurance, and reinsurance products.
KKR invests its own capital alongside its partners' capital, offering opportunities through its capital markets business. The firm's commitment to excellence and growth is evident in its strategic partnerships and significant investments, such as its recent venture with Capital Group to introduce hybrid public-private market investment solutions designed to provide broader access to alternative investments.
In recent news, KKR announced significant developments, including a strategic partnership with Capital Group and a $600 million cash acquisition of Mirus Bio by Gamma Biosciences, a life sciences platform established by KKR.
- Latest News: FS KKR Capital Corp. declared a second-quarter 2024 distribution of $0.75 per share.
- Strategic Partnerships: KKR and Capital Group join forces to create hybrid public-private market investment solutions.
- Acquisitions: Gamma Biosciences, backed by KKR, agreed to sell Mirus Bio to Merck KGaA for $600 million.
For more information, visit KKR's website or follow them on Twitter: @kkr_co.
KKR & Co. Inc. (NYSE: KKR) released its fourth quarter 2022 financial results. The results can be reviewed on KKR’s Investor Center website. A conference call discussing these results is set for February 7, 2023, at 10:00 a.m. ET, accessible to the public via phone and live streaming. KKR continues to implement its disciplined investment approach, providing attractive returns through diverse asset management strategies, including private equity and credit. Additionally, KKR’s insurance subsidiaries offer a spectrum of financial products, contributing to its overall business strategy.
KKR & Co. Inc. (NYSE: KKR) announced that Chief Financial Officer Robert H. Lewin will present at the Credit Suisse 24th Annual Financial Services Forum on February 14, 2023, at 10:15 AM ET. A live webcast of the presentation will be available on KKR's Investor Center website, with a replay accessible shortly after the event for those unable to attend live.
KKR is a leading global investment firm focused on alternative asset management and capital markets solutions, aiming to provide attractive investment returns through a disciplined approach. For more details, visit www.kkr.com.
KKR & Co. Inc. (NYSE: KKR) announced that Co-CEO Scott C. Nuttall will present at the Bank of America Financials Conference 2023 on Tuesday, February 14, 2023, at 8:50 AM ET. A live webcast of the presentation will be accessible on KKR’s Investor Center page, with a replay available shortly after the event for those who cannot attend live. KKR is a leading global investment firm specializing in alternative asset management and insurance solutions, aiming to generate competitive investment returns by employing a disciplined approach and supporting growth in its portfolio.
Groundworks, a leader in foundation repair and water management, has formed a strategic partnership with KKR, a global investment firm. This collaboration will enhance Groundworks' growth by expanding its equity ownership program, allowing over 4,000 employees to become stakeholders. Founded in 2016, Groundworks operates in 33 states and has served over one million customers. KKR's investment, primarily through its North America XIII Fund, is expected to close in Q1 2023, subject to regulatory approvals. Groundworks aims to strengthen its workforce engagement and is positioned for market expansion through organic growth and acquisitions.
KKR & Co. Inc. (NYSE: KKR) will release its financial results for Q4 2022 on February 7, 2023, before the opening of the NYSE. A conference call to discuss these results is scheduled for the same day at 10:00 a.m. ET. Interested parties can participate via phone or listen online through KKR's Investor Center. The replay will be available one hour after the live broadcast. KKR is a global investment firm specializing in alternative asset management, credit, and insurance solutions, aiming to deliver attractive investment returns through disciplined strategies.
FS KKR Capital Corp. (NYSE: FSK) will release its fourth quarter and full year 2022 results on February 27, 2023, after market close. A conference call is scheduled for February 28, 2023, at 9:00 a.m. ET to discuss these results. Interested parties can register for the call through the provided link and access the webcast on the company's Investor Relations website. Additionally, a financial presentation will be made available following the earnings release. FSK specializes in providing customized credit solutions to U.S. middle market companies, focusing on senior secured and subordinated debt investments.
KKR has officially closed its investment in Clinisupplies, a leader in continence care products in the UK, acquired from Healthium. This strategic partnership aims to leverage KKR's global network and expertise to expand Clinisupplies' portfolio and market reach in chronic care. Key appointments to the Board of Directors include Claus Bjerre, Douglas Le Fort, and Oliver Johansen, who bring significant industry experience. KKR's investment comes from its $4 billion Health Care Strategic Growth Fund II, reinforcing its commitment to supporting high-growth healthcare firms.
S&P Global (NYSE: SPGI) has announced an agreement to sell its Engineering Solutions business to KKR for $975 million in cash. This divestiture is expected to yield approximately $750 million in after-tax proceeds, which S&P Global plans to use for share repurchases. The transaction, anticipated to close by the end of Q2 2023, aligns with S&P Global's strategy to focus on core businesses. Engineering Solutions, serving over 6,000 customers globally, will benefit from KKR's investment in innovation and growth. The sale follows S&P Global's outlined intent to divest this segment as announced in November 2022.
FAQ
What is the current stock price of KKR & Co. (KKR)?
What is the market cap of KKR & Co. (KKR)?
What does KKR & Co. Inc. do?
Who founded KKR & Co. Inc.?
What are the main business segments of KKR?
How much are KKR's total managed assets?
What recent strategic partnerships has KKR announced?
What recent acquisitions has KKR been involved in?
Where can I find more information about KKR & Co. Inc.?
What is KKR’s approach to investments?
How can I stay updated with KKR’s news?
What is the significance of KKR's partnership with Capital Group?
